Analysis of SARS-CoV-2 Spike Protein as The Key Target in the Development of Antiviral Candidates for COVID-19 through Computational Study. Journal of Tropical Pharmacy and Chemistry, v. 5, n. 4, p. 347–352, 31 Dec.2021.